glutathione and multiple myeloma Targeting metabolism: How abnormal metabolism contributes to myeloma progression resistance to proteasome inhibitors A recent editorial describes the
A recent editorial describes the science behind a study of mezigdomide, which augments the degradation of the proteins Ikaros and Aiolos, to treat multiple myeloma. Panel A shows the chemical structures Frontiers Multiple myeloma metabolism a treasure trove of therapeutic targets? Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega About Multiple Myeloma UCSF Helen Diller Family Comprehensive Cancer Center
Pay in 4 interest-free payments of $6.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6


